Department of Neurology, University of Florida, Movement Disorders Center, Gainesville, FL, USA; University for Development, Av. Plaza 680, San Carlos de Apoquindo, Las Condes, Santiago, Chile.
Parkinsonism Relat Disord. 2013 Dec;19(12):1113-7. doi: 10.1016/j.parkreldis.2013.08.001. Epub 2013 Sep 7.
Deep Brain Stimulation (DBS) of thalamus in essential tremor (ET) is effective for the treatment of contralateral tremors. Bilateral DBS controls tremors on both sides but is associated with increased morbidity and risks. We evaluated if unilateral surgery had ipsilateral benefits on tremors and thus could be a potentially safer alternative to bilateral DBS.
Medication refractory ET patients undergoing unilateral thalamic DBS were included and longitudinally followed. Tremor rating scale was used to record total motor, arm tremor and activities of daily living (ADL) scores at baseline, six months and at last visit (three or more years after surgery). Postoperative scores were recorded with DBS turned OFF and ON.
Twenty-two patients with a mean follow-up 3.4 ± 0.14 years were enrolled. When baseline scores were compared to scores with the DBS turned ON, significant improvements were noted in total tremor (40%), ADL (67%) and arm tremor scores both on the ipsilateral and the contralateral side at six months and at the last visit of follow-up (all p < 0.05). Ipsilateral arm tremor (∼56%) improvements were milder compared to the contralateral side (∼73%) tremors.
Unilateral thalamic DBS in ET demonstrates significant long-term benefits for ipsilateral arm tremors and can be offered to higher risk and to select patients.
丘脑深部电刺激(DBS)治疗原发性震颤(ET)对治疗对侧震颤有效。双侧 DBS 可控制双侧震颤,但会增加发病率和风险。我们评估了单侧手术是否对同侧震颤有疗效,从而是否可以作为双侧 DBS 的一种潜在更安全的替代方法。
纳入了接受单侧丘脑 DBS 的药物难治性 ET 患者,并进行了纵向随访。震颤评定量表用于记录基线、术后 6 个月和末次随访时(手术 3 年以上)的总运动、手臂震颤和日常生活活动(ADL)评分。术后评分在 DBS 关闭和开启时记录。
共纳入 22 例患者,平均随访 3.4±0.14 年。与 DBS 开启时的评分相比,基线评分在术后 6 个月和末次随访时在同侧和对侧均有显著改善,总震颤(40%)、ADL(67%)和手臂震颤评分均有显著改善(均 p<0.05)。同侧手臂震颤(约 56%)的改善程度比对侧震颤(约 73%)轻。
ET 的单侧丘脑 DBS 显示出对同侧手臂震颤的长期显著益处,可提供给高风险和选择性患者。